The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Treatment Drugs Market Research Report 2024

Global Cancer Treatment Drugs Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1410482

No of Pages : 112

Ask Your Query

Synopsis

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

The global Cancer Treatment Drugs market was valued at US$ 178880 million in 2023 and is anticipated to reach US$ 325040 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.

Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.

North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent. 
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.

This report aims to provide a comprehensive presentation of the global market for Cancer Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Treatment Drugs.

Report Scope

The Cancer Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Roche
  •  Novartis
  •  Celgene
  •  Bristol-Myers Squibb
  •  Amgen
  •  Johnson & Johnson
  •  Pfizer
  •  Takeda
  •  Eli Lilly
  •  AstraZeneca
  •  Astellas
  •  Merck & Co.
  •  Sanofi
  •  Bayer
  •  Biogen Idec
  •  Eisai
  •  Teva
  •  Otsuka
  •  Merck KGaA
  •  Ipsen
  •  AbbVie
  •  Gilead Sciences

Segment by Type

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy (Biologic Therapy)
  • Others

Segment by Application

  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Respiratory or Lung Cancer
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

 

Index

1 Cancer Treatment Drugs Market Overview
    1.1 Product Overview and Scope of Cancer Treatment Drugs
    1.2 Cancer Treatment Drugs Segment by Type
        1.2.1 Global Cancer Treatment Drugs Market Value Comparison by Type (2024-2030)
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy
        1.2.5 Hormonal Therapy (Biologic Therapy)
        1.2.6 Others
    1.3 Cancer Treatment Drugs Segment by Application
        1.3.1 Global Cancer Treatment Drugs Market Value by Application: (2024-2030)
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory or Lung Cancer
        1.3.7 Others
    1.4 Global Cancer Treatment Drugs Market Size Estimates and Forecasts
        1.4.1 Global Cancer Treatment Drugs Revenue 2019-2030
        1.4.2 Global Cancer Treatment Drugs Sales 2019-2030
        1.4.3 Global Cancer Treatment Drugs Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Cancer Treatment Drugs Market Competition by Manufacturers
    2.1 Global Cancer Treatment Drugs Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Cancer Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Cancer Treatment Drugs Average Price by Manufacturers (2019-2024)
    2.4 Global Cancer Treatment Drugs Industry Ranking 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Cancer Treatment Drugs, Product Type & Application
    2.7 Cancer Treatment Drugs Market Competitive Situation and Trends
        2.7.1 Cancer Treatment Drugs Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Cancer Treatment Drugs Players Market Share by Revenue
        2.7.3 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Cancer Treatment Drugs Retrospective Market Scenario by Region
    3.1 Global Cancer Treatment Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Cancer Treatment Drugs Global Cancer Treatment Drugs Sales by Region: 2019-2030
        3.2.1 Global Cancer Treatment Drugs Sales by Region: 2019-2024
        3.2.2 Global Cancer Treatment Drugs Sales by Region: 2025-2030
    3.3 Global Cancer Treatment Drugs Global Cancer Treatment Drugs Revenue by Region: 2019-2030
        3.3.1 Global Cancer Treatment Drugs Revenue by Region: 2019-2024
        3.3.2 Global Cancer Treatment Drugs Revenue by Region: 2025-2030
    3.4 North America Cancer Treatment Drugs Market Facts & Figures by Country
        3.4.1 North America Cancer Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Cancer Treatment Drugs Sales by Country (2019-2030)
        3.4.3 North America Cancer Treatment Drugs Revenue by Country (2019-2030)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Cancer Treatment Drugs Market Facts & Figures by Country
        3.5.1 Europe Cancer Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Cancer Treatment Drugs Sales by Country (2019-2030)
        3.5.3 Europe Cancer Treatment Drugs Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Cancer Treatment Drugs Market Facts & Figures by Country
        3.6.1 Asia Pacific Cancer Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Cancer Treatment Drugs Sales by Country (2019-2030)
        3.6.3 Asia Pacific Cancer Treatment Drugs Revenue by Country (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Cancer Treatment Drugs Market Facts & Figures by Country
        3.7.1 Latin America Cancer Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Cancer Treatment Drugs Sales by Country (2019-2030)
        3.7.3 Latin America Cancer Treatment Drugs Revenue by Country (2019-2030)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Cancer Treatment Drugs Market Facts & Figures by Country
        3.8.1 Middle East and Africa Cancer Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Cancer Treatment Drugs Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Cancer Treatment Drugs Revenue by Country (2019-2030)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Cancer Treatment Drugs Sales by Type (2019-2030)
        4.1.1 Global Cancer Treatment Drugs Sales by Type (2019-2024)
        4.1.2 Global Cancer Treatment Drugs Sales by Type (2025-2030)
        4.1.3 Global Cancer Treatment Drugs Sales Market Share by Type (2019-2030)
    4.2 Global Cancer Treatment Drugs Revenue by Type (2019-2030)
        4.2.1 Global Cancer Treatment Drugs Revenue by Type (2019-2024)
        4.2.2 Global Cancer Treatment Drugs Revenue by Type (2025-2030)
        4.2.3 Global Cancer Treatment Drugs Revenue Market Share by Type (2019-2030)
    4.3 Global Cancer Treatment Drugs Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Cancer Treatment Drugs Sales by Application (2019-2030)
        5.1.1 Global Cancer Treatment Drugs Sales by Application (2019-2024)
        5.1.2 Global Cancer Treatment Drugs Sales by Application (2025-2030)
        5.1.3 Global Cancer Treatment Drugs Sales Market Share by Application (2019-2030)
    5.2 Global Cancer Treatment Drugs Revenue by Application (2019-2030)
        5.2.1 Global Cancer Treatment Drugs Revenue by Application (2019-2024)
        5.2.2 Global Cancer Treatment Drugs Revenue by Application (2025-2030)
        5.2.3 Global Cancer Treatment Drugs Revenue Market Share by Application (2019-2030)
    5.3 Global Cancer Treatment Drugs Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Roche Cancer Treatment Drugs Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 Novartis
        6.2.1 Novartis Corporation Information
        6.2.2 Novartis Description and Business Overview
        6.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Novartis Cancer Treatment Drugs Product Portfolio
        6.2.5 Novartis Recent Developments/Updates
    6.3 Celgene
        6.3.1 Celgene Corporation Information
        6.3.2 Celgene Description and Business Overview
        6.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Celgene Cancer Treatment Drugs Product Portfolio
        6.3.5 Celgene Recent Developments/Updates
    6.4 Bristol-Myers Squibb
        6.4.1 Bristol-Myers Squibb Corporation Information
        6.4.2 Bristol-Myers Squibb Description and Business Overview
        6.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Product Portfolio
        6.4.5 Bristol-Myers Squibb Recent Developments/Updates
    6.5 Amgen
        6.5.1 Amgen Corporation Information
        6.5.2 Amgen Description and Business Overview
        6.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 Amgen Cancer Treatment Drugs Product Portfolio
        6.5.5 Amgen Recent Developments/Updates
    6.6 Johnson & Johnson
        6.6.1 Johnson & Johnson Corporation Information
        6.6.2 Johnson & Johnson Description and Business Overview
        6.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Johnson & Johnson Cancer Treatment Drugs Product Portfolio
        6.6.5 Johnson & Johnson Recent Developments/Updates
    6.7 Pfizer
        6.6.1 Pfizer Corporation Information
        6.6.2 Pfizer Description and Business Overview
        6.6.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Pfizer Cancer Treatment Drugs Product Portfolio
        6.7.5 Pfizer Recent Developments/Updates
    6.8 Takeda
        6.8.1 Takeda Corporation Information
        6.8.2 Takeda Description and Business Overview
        6.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.8.4 Takeda Cancer Treatment Drugs Product Portfolio
        6.8.5 Takeda Recent Developments/Updates
    6.9 Eli Lilly
        6.9.1 Eli Lilly Corporation Information
        6.9.2 Eli Lilly Description and Business Overview
        6.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.9.4 Eli Lilly Cancer Treatment Drugs Product Portfolio
        6.9.5 Eli Lilly Recent Developments/Updates
    6.10 AstraZeneca
        6.10.1 AstraZeneca Corporation Information
        6.10.2 AstraZeneca Description and Business Overview
        6.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.10.4 AstraZeneca Cancer Treatment Drugs Product Portfolio
        6.10.5 AstraZeneca Recent Developments/Updates
    6.11 Astellas
        6.11.1 Astellas Corporation Information
        6.11.2 Astellas Cancer Treatment Drugs Description and Business Overview
        6.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.11.4 Astellas Cancer Treatment Drugs Product Portfolio
        6.11.5 Astellas Recent Developments/Updates
    6.12 Merck & Co.
        6.12.1 Merck & Co. Corporation Information
        6.12.2 Merck & Co. Cancer Treatment Drugs Description and Business Overview
        6.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.12.4 Merck & Co. Cancer Treatment Drugs Product Portfolio
        6.12.5 Merck & Co. Recent Developments/Updates
    6.13 Sanofi
        6.13.1 Sanofi Corporation Information
        6.13.2 Sanofi Cancer Treatment Drugs Description and Business Overview
        6.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.13.4 Sanofi Cancer Treatment Drugs Product Portfolio
        6.13.5 Sanofi Recent Developments/Updates
    6.14 Bayer
        6.14.1 Bayer Corporation Information
        6.14.2 Bayer Cancer Treatment Drugs Description and Business Overview
        6.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.14.4 Bayer Cancer Treatment Drugs Product Portfolio
        6.14.5 Bayer Recent Developments/Updates
    6.15 Biogen Idec
        6.15.1 Biogen Idec Corporation Information
        6.15.2 Biogen Idec Cancer Treatment Drugs Description and Business Overview
        6.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.15.4 Biogen Idec Cancer Treatment Drugs Product Portfolio
        6.15.5 Biogen Idec Recent Developments/Updates
    6.16 Eisai
        6.16.1 Eisai Corporation Information
        6.16.2 Eisai Cancer Treatment Drugs Description and Business Overview
        6.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.16.4 Eisai Cancer Treatment Drugs Product Portfolio
        6.16.5 Eisai Recent Developments/Updates
    6.17 Teva
        6.17.1 Teva Corporation Information
        6.17.2 Teva Cancer Treatment Drugs Description and Business Overview
        6.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.17.4 Teva Cancer Treatment Drugs Product Portfolio
        6.17.5 Teva Recent Developments/Updates
    6.18 Otsuka
        6.18.1 Otsuka Corporation Information
        6.18.2 Otsuka Cancer Treatment Drugs Description and Business Overview
        6.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.18.4 Otsuka Cancer Treatment Drugs Product Portfolio
        6.18.5 Otsuka Recent Developments/Updates
    6.19 Merck KGaA
        6.19.1 Merck KGaA Corporation Information
        6.19.2 Merck KGaA Cancer Treatment Drugs Description and Business Overview
        6.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.19.4 Merck KGaA Cancer Treatment Drugs Product Portfolio
        6.19.5 Merck KGaA Recent Developments/Updates
    6.20 Ipsen
        6.20.1 Ipsen Corporation Information
        6.20.2 Ipsen Cancer Treatment Drugs Description and Business Overview
        6.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.20.4 Ipsen Cancer Treatment Drugs Product Portfolio
        6.20.5 Ipsen Recent Developments/Updates
    6.21 AbbVie
        6.21.1 AbbVie Corporation Information
        6.21.2 AbbVie Cancer Treatment Drugs Description and Business Overview
        6.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.21.4 AbbVie Cancer Treatment Drugs Product Portfolio
        6.21.5 AbbVie Recent Developments/Updates
    6.22 Gilead Sciences
        6.22.1 Gilead Sciences Corporation Information
        6.22.2 Gilead Sciences Cancer Treatment Drugs Description and Business Overview
        6.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
        6.22.4 Gilead Sciences Cancer Treatment Drugs Product Portfolio
        6.22.5 Gilead Sciences Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Cancer Treatment Drugs Industry Chain Analysis
    7.2 Cancer Treatment Drugs Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Cancer Treatment Drugs Production Mode & Process
    7.4 Cancer Treatment Drugs Sales and Marketing
        7.4.1 Cancer Treatment Drugs Sales Channels
        7.4.2 Cancer Treatment Drugs Distributors
    7.5 Cancer Treatment Drugs Customers

 8 Cancer Treatment Drugs Market Dynamics
    8.1 Cancer Treatment Drugs Industry Trends
    8.2 Cancer Treatment Drugs Market Drivers
    8.3 Cancer Treatment Drugs Market Challenges
    8.4 Cancer Treatment Drugs Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock